Phase 2 Trial of Mitapivat - The Cooley's Anemia Foundation

Agios Pharmaceuticals Provides Update on Phase 2 Study of Mitapivant in Non-Transfusion-Dependent Thalassemia » Phase 2 Trial of Mitapivat

This entry was posted on Friday, June 12th, 2020 at 5:21 pm and is filed under . You can follow any responses to this entry through the RSS 2.0 feed. Both comments and pings are currently closed.

Comments are closed.